Loading…
Gujarat Themis Biosyn (GUJTHEM)₹379.65−1.12%Pharmaceuticals
At the end of the Jun 2026 quarter, Gujarat Themis Biosyn's shareholders were: promoters 70.92%, FIIs 1.75%, DIIs 1.16%, public 26.17%. Promoter holding is up 0.01 percentage points from 70.91% a quarter earlier. FII holding is down 0.75 percentage points from 2.50% a year earlier. 5.41% of promoter shares were pledged. It had 27,021 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.05% | 70.92% | 70.92% | 70.92% | 70.92% | 70.92% | 70.92% | 70.92% | 70.92% | 70.92% | 70.91% | 70.92% |
| FIIs | 0.01% | 0.86% | 1.04% | 1.43% | 1.48% | 1.41% | 1.90% | 2.50% | 2.94% | 1.95% | 1.79% | 1.75% |
| DIIs | 0.03% | 0.04% | 0.81% | 1.17% | 1.16% | 1.16% | 1.16% | 1.16% | 1.16% | 1.16% | 1.16% | 1.16% |
| Public | 24.91% | 28.18% | 27.23% | 26.48% | 26.44% | 26.51% | 26.02% | 25.42% | 24.98% | 25.97% | 26.14% | 26.17% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 5.41% |
| Number of shareholders | 19,854 | 28,667 | 29,588 | 30,292 | 31,284 | 30,947 | 30,685 | 28,957 | 28,331 | 27,336 | 26,897 | 27,021 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Pharmaceutical Business Group [India] Ltd | Promoter | 47.03% | 0.00 |
| Themis Medicare Limited | Promoter | 20.95% | −2.29 |
| Sachin Dinesh Patel | Promoter | 2.31% | New |
| Quant Mutual Fund - Quant Manufacturing Fund | DII | 1.16% | 0.00 |
| Ayushmat Ltd | FII | 1.11% | 0.00 |
| Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel (Trustees of Vividhmargi Trust) | Promoter | 0.61% | New |
| Anay Rupen Choksi | Promoter | 0.02% | 0.00 |
| Nysha Rupen Choksi | Promoter | 0.02% | 0.00 |
| Vividhmargi Trust (Trustees - Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel and Reena Sachin Patel ) | Promoter | Exited | — |
| Dinesh Shantilal Patel | Promoter | 0.00% | 0.00 |
| Jayshree D Patel | Promoter | 0.00% | 0.00 |
| Reena S Patel | Promoter | 0.00% | 0.00 |
Promoters held 70.92% of Gujarat Themis Biosyn at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.75% (down 0.04 percentage points from 1.79% a quarter earlier) and domestic institutions (DIIs) held 1.16% (unchanged at 1.16% a quarter earlier).
Yes. 5.41% of promoter shares were pledged at the end of the Jun 2026 quarter.
Gujarat Themis Biosyn had 27,021 shareholders at the end of the Jun 2026 quarter, against 28,957 a year earlier.
Quant Mutual Fund - Quant Manufacturing Fund (DII) held 1.16% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.